Covered recipient · General Payments record
BROOKE E SANDERS
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology
General Payments · PY2023–2024
$291.13
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $192.94 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genmab U.S., Inc. | $67.67 | 2 |
| Merck Sharp & Dohme Corporation | $46.52 | 2 |
| ABBVIE INC. | $36.09 | 2 |
| Acerta Pharma LLC | $21.39 | 1 |
| EISAI INC. | $21.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.93 | 06/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106013459 | CMS |
| ABBVIE INC. | $17.16 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106013461 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.39 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104676041 | CMS |
| Eisai Inc. | $21.27 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110734941 | CMS |
| Genmab U.S., Inc. | $25.07 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126825075 | CMS |
| Genmab U.S., Inc. | $42.60 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126825073 | CMS |
| Merck Sharp & Dohme LLC | $27.54 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141757082 | CMS |
| Merck Sharp & Dohme LLC | $18.98 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141888593 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.